当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2016年第35期
编号:13070006
自噬在阿尔茨海默病发病机制中的作用及治疗策略(5)
http://www.100md.com 2016年12月15日 中国医药导报 2016年第35期
     [25] Karch CM,Jeng AT,Nowotny P,et al. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains [J]. PLoS One,2012,7(11):e50976.

    [26] Matsubara E,Soto C,Governale S,et al. Apolipoprotein J and Alzheimer's amyloid beta solubility [J]. Biochem J,1996, 316(2):671-679.

    [27] Caccamo A,Majumder S,Richardson A,et al. Molecular interplay between mammalian target of rapamycin(mTOR),amyloid-beta,and tau:effects on cognitive impairments [J]. J Biol Chem,2010,285(17):13107-13120.

    [28] Jiang T,Yu JT,Zhu XC,et al. Temsirolimus promotes autophagic clearance of amyloid-β and provide sprotective effects in cellular and animal models of Alzheimer's disease [J]. Pharmacol Res,2014,81:54-63.

    [29] Nalivaeva NN,Belyaev ND,Turner AJ. Sodium valproate:an old drug with new roles [J]. Trends Pharmacol Sci,2009,30(10):509-514.

    [30] 高文凡,陳飞虎,葛金芳,等.钙络合剂BAPTA-AM对胞外酸化诱导大鼠关节软骨细胞自噬作用的影响及其可能机制[J].中国药理学通报,2015,31(5):655-659.

    [31] Anekonda TS,Quinn JF. Calcium channel blocking as a therapeutic strategy for Alzheimer's disease:the case for isradipine [J]. Biochim Biophys Acta,2011,1812(12):1584-1590.

    [32] Gu J,Congdon EE,Sigurdsson EM. Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathology [J]. J Biol Chem,2013,288(46):33081-33095.

    (收稿日期:2016-09-15 本文编辑:李亚聪), http://www.100md.com(李畅 刘明妍)
上一页1 2 3 4 5